SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027551
Filing Date
2023-08-10
Accepted
2023-08-10 16:16:02
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 592252
2 ex31-1.htm EX-31.1 8255
3 ex31-2.htm EX-31.2 8203
4 ex32-1.htm EX-32.1 6838
5 pipe_001.jpg GRAPHIC 82625
  Complete submission text file 0001493152-23-027551.txt   3464840

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pcsa-20230630.xsd EX-101.SCH 28888
7 XBRL CALCULATION FILE pcsa-20230630_cal.xml EX-101.CAL 37129
8 XBRL DEFINITION FILE pcsa-20230630_def.xml EX-101.DEF 115581
9 XBRL LABEL FILE pcsa-20230630_lab.xml EX-101.LAB 244100
10 XBRL PRESENTATION FILE pcsa-20230630_pre.xml EX-101.PRE 195640
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 347147
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 231159696
SIC: 2834 Pharmaceutical Preparations